US Cardiac Monitoring Devices Market: Industry Analysis and Forecast (2024-2030)

The US Cardiac Monitoring Devices Market size was valued at USD 13.5 Billion in 2023 and the total US Cardiac Monitoring Devices revenue is expected to grow at a CAGR of 3.1% from 2023 to 2030, reaching nearly USD 16.72 Billion in 2030.
US Cardiac Monitoring Devices Market Overview
The US Cardiac Monitoring Devices Market is undergoing a transformative phase, influenced by technological innovations and evolving healthcare demands. The complete report researches the intricate dynamics defining the market, exploring anticipated trends, technological breakthroughs, and potential disruptions. It meticulously examines regulatory framework, competitive landscapes, patient demographics, and market positioning to provide a comprehensive understanding of the sector.

To know about the Research Methodology :- Request Free Sample Report

Segmenting the market by product type (ECG Monitors, Event Recorder, Implantable Cardiac Loop Recorders, Pacemaker, Defibrillator, Cardiac Resynchronization Therapy (CRT) Devices, Smart Wearables, and Other), end users (Hospitals, Clinics, Ambulatory Surgical Centers, And Home Settings), and technological advancements, the report aims to provide stakeholders with critical insights for informed decision making in this rapidly evolving sector. The 2023 showcases a remarkable surge in demand, with an estimated 30% increase in the utilization of cardiac monitoring devices, depicting a growing reliance on these technologies for heart health management. This report offers an all-encompassing view of the US cardiac monitoring devices market, encapsulating its current landscape and future projections. The report offers a holistic view of the US ambulance services market in 2023.
US Cardiac Monitoring Devices Market Dynamics:
Wearable Technology Revolutionizes Heart Health with a 35% Revenue Boost

The integration of wearable technology into cardiac monitoring has reshaped healthcare, transforming how patients are treated. In 2022, the US cardiac monitoring devices market surged, largely driven by wearable technology’s substantial impact. The wearable cardiac monitors contributed a remarkable 35% to the market revenue, making a robust 15% leap from the 2022 year boosting the US cardiac monitoring devices market. Smartwatches with 40% of the market, fitness bands with 35% market, and patches with 15% of the market, embedded with sensors for continuous monitoring revolutionized heart health assessment. They track heart rate (boosting monitoring accuracy by 20%), ECG readings, blood pressure, and oxygen levels. Additionally, these devices spurred a new era in remote patient monitoring. Their connectivity features enabled seamless data transmission to healthcare pros, allowing remote diagnosis and interventions and boosting the US cardiac monitoring devices market. User-friendly designs and AI-powered analytics provided deep health insights, allowing users to track both clinical metrics and lifestyle factors impacting heart health. This integration signifies a pivotal shift toward tailored, proactive healthcare, improving patient engagement and clinical outcomes in cardiac care increasing demand for wearable technologies.


US Cardiac Monitoring Devices Market Segment Analysis:
Based on Product Type, the ECG Monitors segment held the largest market share of more than 30% and dominated the US Cardiac Monitoring Devices industry in 2023. The segment is further expected to grow at a CAGR of 3.3% and maintain its dominance during the forecast period. The rising demand is driven by factors such as diagnosing a wide range of cardiac conditions, pre-and post-operative monitoring, evaluating medication effectiveness, and managing chronic cardiac conditions are expected to be the major factors driving the segment growth.



Besides that, the Event Recorder segment is expected to grow at a rapid CAGR and offer lucrative growth opportunities for US cardiac monitoring device manufacturers all across the United States during the forecast period. The growing demand is projected thanks to diagnosing infrequent or paroxysmal arrhythmias, evaluating the effectiveness of antiarrhythmic medications, investigating unexplained syncope (fainting), and screening for potential arrhythmias in high-risk patients are expected to be the major factors driving the segment growth. Many factors lead to such adoption thanks to convenient and portable, cost-effective, non-invasive, and targeted data capture is boosting the US cardiac monitoring devices market.

The major key players in the US cardiac monitoring device market are Physionet, BioSig technologies, Evoke Medical, Wellue, and AliveCor. Thus, increasing demand for the US cardiac monitoring devices market supports the segment growth.
US Cardiac Monitoring Devices Market Scope:Inquire Before Buying



US Cardiac Monitoring Devices Market


Report Coverage
Details


Base Year:
2023
Forecast Period:
2024-2030


Historical Data:
2018 to 2023
Market Size in 2023:
US $ 13.5 Bn.


Forecast Period 2024 to 2030 CAGR:
3.1%
Market Size in 2030:
US $ 16.72 Bn.


 Segments Covered:
by Product Type
ECG Monitors
Event Recorder
Implantable Cardiac Loop Recorder
Pacemaker
Defibrillator
Cardiac Resynchronization Therapy (CRT) Devices
Smart Wearable
Other


by End User
Hospitals
Clinics
Ambulatory Surgical Centers
Home Settings



US Cardiac Monitoring Devices Market Key Players:
1. Boston Scientific
2. Abbott Laboratories
3. GE Healthcare
4. Hill-Rom Holdings
5. BioTelemetry
6. ACS Diagnostics
7. Alivecor, Inc
8. Philips Healthcare
9. Mortara Instrument Corp
10. Spacelabs Healthcare
11. Coala Life
12. Medicalgorithmics
13. iRhythm technologies
14. Medtronic
15. Biotronik
16. St.Jude Medical
17. Kardia

Frequently Asked Questions:

1. What is the growth rate of Market?
Ans: The Market is growing at a CAGR of 3.1% during forecasting period 2024-2030.

2. What is scope of the Market report?
Ans: Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

3. Who are the key players in Market?
Ans: The important key players in the Market are – Boston Scientific , Abbott Laboratories, GE Healthcare , Hill-Rom Holdings, BioTelemetry, ACS Diagnostics, Alivecor, Inc, Philips Healthcare, Mortara Instrument Corp, Spacelabs Healthcare, Coala Life, Medicalgorithmics, iRhythm technologies, Medtronic, Biotronik, St.Jude Medical, Kardia.

4. What is the study period of this Market?
Ans: The  Market is studied from 2023 to 2030.